Trinity PR is supporting our client CME Medical with the launch of their new campaign to bring attention to the upcoming National Patient Safety Agency (NPSA) deadline; recommending that ambulatory syringe drivers with rate settings of millimetres (mm) are phased out by December 2015 to reduce the potential of harm to patients. The campaign is targeted towards NHS Trusts, nursing homes, cares homes and CCG’s to ensure full compliance across all areas.
The T34TM ambulatory syringe pump has been widely adopted throughout the UK, with the CME Medical team already helping around 85% of the UK to make the transition to a safer pump since its launch in 2006.
The NPSA guidelines provide information for manufacturers on what design features it believes would improve the safe use of infusion devices in the future. In addition, it informs healthcare professionals and organisations when choosing and purchasing infusion devices what they need to consider for safety, efficiency and ease of use. By bringing attention to the deadline, CME Medical urges those who currently do not practice with a pump compliant with the NPSA requirements to improve patient safety by switching to a pump that does conform to the standards.
As part of its ongoing commitment to its customers and patient safety, CME Medical’s campaign will include an offer of buy one get one free on consumable kits as well as a years servicing for £70.00 if booked before the 31st March 2015 (Normal price £80.00)
John Carrington, Managing Director at CME Medical comments: “At CME Medical we believe that safety should be at the top of the “checklist” when choosing a product. The T34TM is the gold standard in the sector and meets and exceeds all of the standards set out by the NPSA. We are totally committed to helping our customers and healthcare professionals deliver safe, efficient and quality compliant clinical practice and consistency of patient care. We understand the challenge that organisations face in the transition from long-established equipment to an ambulatory syringe driver, therefore we are keen to offer support to those undertaking this task, helping them to provide their patients with the best care possible.”